Grifols Worldwide Operations Ltd

Grifols Worldwide Operations Limited is a leading global healthcare organisation that harnesses the power of human plasma, diagnostics and life-science technologies to improve the health and well-being of patients worldwide. The company develops and manufactures plasma-derived medicines, a broad portfolio of biopharmaceuticals and specialised solutions for transfusion medicine, enabling millions of individuals with chronic, rare or acute conditions to lead more productive lives.

Grifols' activities span four core areas: Biopharma, delivering lifegiving plasma-based therapies; Diagnostics, providing advanced testing tools; Bio Supplies, offering essential laboratory and clinical reagents; and Healthcare Solutions for hospitals, supporting safe and efficient transfusion practices. The group is also recognised for its commitment to ethical leadership, sustainability and donor care, with a strong focus on research, innovation and the development of new therapeutic opportunities across immunology, hepatology, pulmonology, haematology, neurology and infectious diseases.

Operating from its international headquarters, Grifols serves patients, donors and healthcare providers across the globe, combining more than a century of expertise with a forward-looking vision for a healthier, more sustainable society.